Our Research & Development Pipeline

Steba biotech conducts research programs in various solid tumors, including:

Padeliporfin ImPACT Pipeline Overview

Preclinical PoC Pivotal
Upper tract Urothelial Carcinoma (UTUC) Low Grade
Upper tract Urothelial Carcinoma (UTUC) High Grade
Bladder Cancer
Lung Cancer Central Airway Obstruction (CAO)
Lung Cancer Peripheral Tumor Ablation (PTA)
Esophagus Cancer
Pancreatic Cancer
ImPact Universe of indications
Uro-Oncology Franchise
Urinary tract

Upper Tract Urothelial Carcinoma (I and III)

Learn more
Bladder Cancer

Bladder Cancer (PoC)

Learn more
Prostate Cancer

Low-Risk Localized-PCa (M)

Intermediate-Risk Localized-PCa (II and III)

Learn more
Lung cancer Franchise
Lung Cancer

Central Airway

Peripheral Tumor Ablation (PoC)

Learn more
Gl-Oncology Franchise
Esophageal Cancer

Obstruction Relief (I)

Learn more
Pancreatic Cancer

Unresectable Disease (PoC)

Learn more